Alzheimer’s Research & Therapy

BMC

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Alzheimer’s Research & Therapy is an open-access journal published by BMC in United Kingdom, publishing in english. It is listed in DOAJ and MEDLINE and PUBMED according to the sources read. Declared publication charge: 3,490 EUR. Declared review time at DOAJ: 16 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
BMC
ISSN
1758-9193
Country
United Kingdom
Languages
english
Access
Open access
Declared publication charge
3,490 EUR
Articles in DOAJ
1859
Declared review time
16 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2015-11-16
  • MEDLINE · 2015-01-01
  • PUBMED · 2009-07-09
Indexing
DOAJ · MEDLINE · PUBMED
APC
3,490 EUR
Declared review time (DOAJ)
16 weeks
Actual review time (measured)
122 days received→accepted — computed from PubMed (n=94)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

1859

Most recent article

last month

Average review time (journal-declared via DOAJ)

16weeks

Works in OpenAlex

2325

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

145

i10-index

1592

From OpenAlex open data (CC0).

Editorial & policy13
Last DOAJ review date
2026-03-17
Added to DOAJ
2015-11-16
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSLOCKSSPMCPorticoINIST
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
92%
ORCID iDs in current deposits
10%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity4
Alternate titles
Alzheimer's research and therapy
Source type
journal
NLM unique ID (PubMed)
101511643
Society affiliations
Alzheimer's Research UK
Classification3

Subjects (DOAJ)

Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system

LCC codes

RC321-571RC346-429

Subject areas

  • Dementia and Cognitive Impairment Research
  • Dementia and Cognitive Impairment Research
  • Alzheimer's disease research and treatments
  • Alzheimer's disease research and treatments
  • Functional Brain Connectivity Studies
  • Functional Brain Connectivity Studies
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Intracerebral and Subarachnoid Hemorrhage Research
Show all subjects (50)
  • Intracerebral and Subarachnoid Hemorrhage Research
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Neurological Disease Mechanisms and Treatments
  • Neurological Disease Mechanisms and Treatments
  • Cholinesterase and Neurodegenerative Diseases
  • Cholinesterase and Neurodegenerative Diseases
  • Amyotrophic Lateral Sclerosis Research
  • Amyotrophic Lateral Sclerosis Research
  • Cancer-related cognitive impairment studies
  • Cancer-related cognitive impairment studies
  • Parkinson's Disease Mechanisms and Treatments
  • Parkinson's Disease Mechanisms and Treatments
  • Traumatic Brain Injury Research
  • Traumatic Brain Injury Research
  • Tryptophan and brain disorders
  • Cerebrospinal fluid and hydrocephalus
  • Tryptophan and brain disorders
  • Cerebrospinal fluid and hydrocephalus
  • Schizophrenia research and treatment
  • Schizophrenia research and treatment
  • Neuroscience and Neuropharmacology Research
  • Health Systems, Economic Evaluations, Quality of Life
  • Neuroscience and Neuropharmacology Research
  • Health Systems, Economic Evaluations, Quality of Life
  • Genetic Associations and Epidemiology
  • Advanced Neuroimaging Techniques and Applications
  • Advanced Neuroimaging Techniques and Applications
  • Genetic Associations and Epidemiology
  • S100 Proteins and Annexins
  • S100 Proteins and Annexins
  • Neurogenesis and neuroplasticity mechanisms
  • Neurogenesis and neuroplasticity mechanisms
  • Nutritional Studies and Diet
  • Nutritional Studies and Diet
  • Neurobiology of Language and Bilingualism
  • Computational Drug Discovery Methods
  • Computational Drug Discovery Methods
  • Neurobiology of Language and Bilingualism
  • Metabolomics and Mass Spectrometry Studies
  • Metabolomics and Mass Spectrometry Studies
  • Intensive Care Unit Cognitive Disorders
  • Intensive Care Unit Cognitive Disorders

Keywords (DOAJ)

  • alzheimer's disease
  • dementia
  • neurodegenerative diseases

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: